Home > Insider Trading > Filing (0001437749-22-010726)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
810509	Navidea Biopharmaceuticals Inc.	NAVB	In Vitro & In Vivo Diagnostic Substances (2835)	311080091

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753763	Jr. K John Scott	4995 Bradenton Ave., Suite 240 Dublin OH 43017		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-04-30	2,500	$0.00	8,093,395	No	4	A	Direct
Series G Redeemable Preferred Stock	Acquisiton	2022-04-10	3,260	$0.00	3,260	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series E Redeemable Convertible Preferred Stock	Disposition	2022-04-10	50,000	$2.30	2,173,913	$2.30
Common Stock	Series F Redeemable Convertible Preferred Stock	Acquisiton	2022-04-10	1,740	$0.80	2,175,000	$0.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2021-03-02	2022-09-02	No	4	S	Direct
1,740	2022-04-10		No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,139	Indirect	By spouse and children

Footnotes

Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
Issuance deferred at the request of the Reporting Person.
Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed to have shared voting and/or dispositive power with respect to such shares.
Series E Redeemable Convertible Preferred Stock, par value $.001 per share, was exchanged for Series F Redeemable Convertible Preferred Stock, par value $.001 per share, and Series G Redeemable Preferred Stock, par value $.001 per share.
Series F Redeemable Convertible Preferred Stock, par value $.001 per share, is convertible at any time and has no expiration date.